Latest Business and People News
Updated employee announcements, business news, awards, and recognition in the industry today.
People News
Synteract, a full-service, international CRO, announced that Karl Deonanan has joined as Chief Financial Officer to lead their Finance and Contracts Proposals organizations and Jack Shannon has joined as Chief Commercial Officer.
Tom Haag
Bill Byrom
CRF Health, a global provider of patient-centered eSource technology and service solutions, has announced the appointment of Tom Haag, Vice President, Quality Assurance and Bill Byrom, Vice President of Product Strategy & Innovation.
Syneos Health, a fully integrated biopharmaceutical solutions organization, has announced the appointment of Lisa van Capelle as Chief Human Resources Officer.
Ashfield, part of UDG Healthcare, an international healthcare services provider, has announced the appointment of Doug Burcin as President of Ashfield Healthcare Communications.
Bracket, a clinical trial technology and specialty services provider, announced the appointment of Michael P. Nolte as CEO who brings along years of experience as the former CEO of Influence Health.
Business News
CluePoints, a provider of RBM and Data Quality Oversight solutions for clinical trials, has been honored in this year’s Biotechnology Awards with the CluePoints solution being named the “Best Risk-Based Monitoring Solution”.
OmniComm Systems, Inc. has announced that it has been named to the 2018 OTCQX Best 50, a ranking of top-performing companies traded on the OTCQX Best Market last year for their 2017 performance.
Senior executives in manufacturing operations within large global corporations have selected the Thermo Fisher Scientific’s InSight wireless cold storage monitoring solution as the winner of the 2017 Manufacturing Leaders Innovation Award.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Phase III PROMINENT Trial Initiated to Evaluate Felzartamab for Primary Membranous Nephropathy
June 30th 2025The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous nephropathy, a serious autoimmune kidney disorder with no FDA-approved therapies.
